14159 capital gp llc - through partnership investment history in Pharmacyclics inc

Filed on 2012-01-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-004224.txt Sec File: edgar/data/1317493/0001144204-12-004224-index.htm

2012-01-26 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1944 shares at $17.8928 remaining shares owned 195858

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-004224.txt Sec File: edgar/data/1317493/0001144204-12-004224-index.htm

2012-01-26 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 4360 shares at $17.9507 remaining shares owned 193914

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-004224.txt Sec File: edgar/data/1317493/0001144204-12-004224-index.htm

2012-01-25 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 454 shares at $18.4325 remaining shares owned 189554

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-004224.txt Sec File: edgar/data/1317493/0001144204-12-004224-index.htm

2012-01-25 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2792 shares at $18.5473 remaining shares owned 189100

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-004224.txt Sec File: edgar/data/1317493/0001144204-12-004224-index.htm

2012-01-24 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2202 shares at $18.007 remaining shares owned 186308

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-004224.txt Sec File: edgar/data/1317493/0001144204-12-004224-index.htm

2012-01-24 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1193 shares at $17.8569 remaining shares owned 184106

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc sold 2 shares at $1.4976 remaining shares owned 0

Call Option Pharmacyclics Inc Pcyc exercise date 2012-01-20 exercise price 15 has valueitem expiration due date 2012-01-21 underlying security shares 200 underlying security title Common Stock

f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc sold 5 shares at $1.25 remaining shares owned 2

Call Option Pharmacyclics Inc Pcyc exercise date 2012-01-19 exercise price 15 has valueitem expiration due date 2012-01-21 underlying security shares 500 underlying security title Common Stock

f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2 shares at $1.4976 remaining shares owned 7

Call Option Pharmacyclics Inc Pcyc exercise date 2012-01-20 exercise price 15 has valueitem expiration due date 2012-01-21 underlying security shares 200 underlying security title Common Stock

f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-19 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 5 shares at $1.25 remaining shares owned 5

Call Option Pharmacyclics Inc Pcyc exercise date 2012-01-19 exercise price 15 has valueitem expiration due date 2012-01-21 underlying security shares 500 underlying security title Common Stock

f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-23 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1201 shares at $16.8399 remaining shares owned 182913

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-23 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1923 shares at $16.8784 remaining shares owned 181712

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-23 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1149 shares at $16.8975 remaining shares owned 179789

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 200 shares at $15 remaining shares owned 178640

Common Stock Pharmacyclics Inc Pcyc Transaction code: X Exercise of in-the-money or at-the-money derivatives securities (usually options)

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 500 shares at $15 remaining shares owned 178440

Common Stock Pharmacyclics Inc Pcyc Transaction code: X Exercise of in-the-money or at-the-money derivatives securities (usually options)

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1824 shares at $16.4388 remaining shares owned 177940

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-20 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 4712 shares at $16.4096 remaining shares owned 176116

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-19 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 66 shares at $15.8091 remaining shares owned 171404

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-19 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 278 shares at $16.0686 remaining shares owned 171338

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2012-01-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-12-003575.txt Sec File: edgar/data/1317493/0001144204-12-003575-index.htm

2012-01-19 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 594 shares at $16.0682 remaining shares owned 171060

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-12-06 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-068614.txt Sec File: edgar/data/1317493/0001144204-11-068614-index.htm

2011-12-02 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1895 shares at $15.4231 remaining shares owned 170466

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-12-06 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-068614.txt Sec File: edgar/data/1317493/0001144204-11-068614-index.htm

2011-12-02 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 465 shares at $15.3853 remaining shares owned 168571

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-067763.txt Sec File: edgar/data/1317493/0001144204-11-067763-index.htm

2011-11-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1815 shares at $14.2583 remaining shares owned 168106

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-067763.txt Sec File: edgar/data/1317493/0001144204-11-067763-index.htm

2011-11-29 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2568 shares at $14.1177 remaining shares owned 166291

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-067763.txt Sec File: edgar/data/1317493/0001144204-11-067763-index.htm

2011-11-28 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1393 shares at $13.3784 remaining shares owned 163723

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-30 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-067763.txt Sec File: edgar/data/1317493/0001144204-11-067763-index.htm

2011-11-28 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2659 shares at $13.3205 remaining shares owned 162330

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-066874.txt Sec File: edgar/data/1317493/0001144204-11-066874-index.htm

2011-11-23 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 747 shares at $12.7601 remaining shares owned 159671

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-066874.txt Sec File: edgar/data/1317493/0001144204-11-066874-index.htm

2011-11-22 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2685 shares at $12.8664 remaining shares owned 158924

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-066874.txt Sec File: edgar/data/1317493/0001144204-11-066874-index.htm

2011-11-22 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 807 shares at $12.5075 remaining shares owned 156239

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-066874.txt Sec File: edgar/data/1317493/0001144204-11-066874-index.htm

2011-11-21 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2143 shares at $12.0141 remaining shares owned 155432

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-11-23 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-066874.txt Sec File: edgar/data/1317493/0001144204-11-066874-index.htm

2011-11-21 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 635 shares at $12.2523 remaining shares owned 153289

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-10-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-056344.txt Sec File: edgar/data/1317493/0001144204-11-056344-index.htm

2011-10-03 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 2195 shares at $11.616 remaining shares owned 152654

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-10-04 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-056344.txt Sec File: edgar/data/1317493/0001144204-11-056344-index.htm

2011-10-03 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 915 shares at $11.5421 remaining shares owned 150459

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-08-24 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-049604.txt Sec File: edgar/data/1317493/0001144204-11-049604-index.htm

2011-08-22 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 1001 shares at $9.9276 remaining shares owned 149544

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-08-24 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-049604.txt Sec File: edgar/data/1317493/0001144204-11-049604-index.htm

2011-08-22 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 3339 shares at $9.9693 remaining shares owned 148543

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-08-24 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-049604.txt Sec File: edgar/data/1317493/0001144204-11-049604-index.htm

2011-08-22 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc bought 86 shares at $9.9982 remaining shares owned 145204

Common Stock Pharmacyclics Inc Pcyc Transaction code: P Open market or private purchase of securities

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they or any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons and each of them disclaim beneficial ownership or securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., a limited partnership the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.


Filed on 2011-08-24 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 3

Accession 0001144204-11-049598.txt Sec File: edgar/data/1317493/0001144204-11-049598-index.htm

2011-08-22 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Pharmacyclics Inc remaining shares owned 145118

Common Stock Pharmacyclics Inc Pcyc

f1 in addition to 14159 capital (gp), llc, this form 3 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are the controlling members of 14159 capital (gp), llc.